DiscGenics Allowed 9 New Patents

DiscGenics announced allowance of 9 additional patents, including two in the U.S. and seven in EU markets. The company is developing spinal stem cell therapeutics.

This expands the company's global intellectual property portfolio to 24 issued patents covering the proprietary culture process and novel Discogenic Cell technology that is the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us